Optimal Management of Lung Function Data to Drive Successful Respiratory Clinical Trial Outcomes

Publish Date:
July 20, 2015
Phil Lake, Executive Director of Biopharmaceutical Development, Jim Sowash, Director of Respiratory and Clinical Systems, ERT

Because the prevalence and overall importance of COPD as a health problem is increasing, clinical trials involving spirometry as a metric are becoming more common. However, due to a variety of factors, the clinical data being generated in these trials is often of insufficient quality to stand up to regulatory scrutiny. In this informative webinar, we’ll look at the elements of variability in measuring lung function as well as the ATS/ERS criteria for standardizing technique.

The presenters discuss methodology created to help overcome inconsistencies and dramatically improve lung function data collection and management in global pulmonary trials, thereby improving study outcomes. In this webinar, participants can expect to:

  • Understand the areas of variability in lung function testing
  • Learn the impact of high-quality data variability in respiratory studies
  • Procure the benefits of centralized spirometry control